News
News Headlines
Velpanat, a sofosbuvir-velpatasvir fixed dose combination, is generic version of Gilead''s Epclusa. Natco Pharma Limited has launched Velpanat – a fixed dose combination medicine containing sofosbuvir (400 mg) velpatasvir (100 mg) – for the treatment of hepatitis C.
Available now at very good price with us.
contact.
For more Information-
News Headlines
Lancer health care launched langra 100 tablets. For the use of men.
For more Information-
News Headlines
HEPATITIS MEDICINES WERE VERY EXPENSIVE. ALL PATIENTS WERE NOT ABLE TO AFFORD THE SAME. NOW ALL PATENTS GIVEN BY USA COMPANY TO INDIAN PHARMACEUTICALS COMPANIES AND MANUFACTURE HERE IN INDIA.
ALMOST ALL HEPATITIS MEDICINES AVAILABLE IN INDIA NOW.
For more Information-
Product Videos
Contact Us
Sandeep (Proprietor)
Lancer Healthcare
2nd Floor, 1541/A-19, Behind State Bank Of India, Bhagirath Palace, Chandni Chowk
New Delhi - 110006, Delhi, India